

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.73825486 |
| 2 | regulation of vitamin metabolic process (GO:0030656) | 5.50691853 |
| 3 | proline biosynthetic process (GO:0006561) | 5.45709561 |
| 4 | regulation of chronic inflammatory response (GO:0002676) | 5.34337324 |
| 5 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.83881009 |
| 6 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.80963446 |
| 7 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.79393225 |
| 8 | regulation of fever generation (GO:0031620) | 4.78035393 |
| 9 | positive regulation of heat generation (GO:0031652) | 4.77449511 |
| 10 | regulation of integrin activation (GO:0033623) | 4.71183719 |
| 11 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.54034458 |
| 12 | embryonic process involved in female pregnancy (GO:0060136) | 4.48719109 |
| 13 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.34798980 |
| 14 | regulation of interferon-alpha production (GO:0032647) | 4.23187445 |
| 15 | positive regulation of protein homooligomerization (GO:0032464) | 4.22648296 |
| 16 | proline metabolic process (GO:0006560) | 4.22219693 |
| 17 | regulation of podosome assembly (GO:0071801) | 4.16447783 |
| 18 | activation of MAPKKK activity (GO:0000185) | 4.12431530 |
| 19 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.05029884 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.03936213 |
| 21 | cellular response to type I interferon (GO:0071357) | 4.03936213 |
| 22 | regulation of chemokine biosynthetic process (GO:0045073) | 3.98329772 |
| 23 | response to type I interferon (GO:0034340) | 3.97396454 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.85916702 |
| 25 | negative T cell selection (GO:0043383) | 3.84221370 |
| 26 | response to peptidoglycan (GO:0032494) | 3.81207261 |
| 27 | transcription from mitochondrial promoter (GO:0006390) | 3.79387668 |
| 28 | protein localization to endosome (GO:0036010) | 3.78714997 |
| 29 | activated T cell proliferation (GO:0050798) | 3.78255736 |
| 30 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.71526453 |
| 31 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.65438548 |
| 32 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.60997328 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.57920244 |
| 34 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.54123528 |
| 35 | positive thymic T cell selection (GO:0045059) | 3.51920635 |
| 36 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.51753666 |
| 37 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.51296247 |
| 38 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.51139269 |
| 39 | creatine metabolic process (GO:0006600) | 3.50035014 |
| 40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.50000276 |
| 41 | regulation of protein homooligomerization (GO:0032462) | 3.49400253 |
| 42 | regulation of heat generation (GO:0031650) | 3.47397924 |
| 43 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.47355225 |
| 44 | adhesion of symbiont to host (GO:0044406) | 3.45707538 |
| 45 | regulation of immunoglobulin secretion (GO:0051023) | 3.43777843 |
| 46 | cellular response to interferon-alpha (GO:0035457) | 3.42522605 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.41368119 |
| 48 | virion attachment to host cell (GO:0019062) | 3.40608914 |
| 49 | adhesion of symbiont to host cell (GO:0044650) | 3.40608914 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36929477 |
| 51 | embryonic placenta development (GO:0001892) | 3.33484902 |
| 52 | T-helper 1 type immune response (GO:0042088) | 3.30183422 |
| 53 | thymic T cell selection (GO:0045061) | 3.26024489 |
| 54 | positive regulation of interferon-alpha production (GO:0032727) | 3.23990614 |
| 55 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.23918294 |
| 56 | negative regulation of amino acid transport (GO:0051956) | 3.22415630 |
| 57 | apoptotic process involved in morphogenesis (GO:0060561) | 3.20268540 |
| 58 | germinal center formation (GO:0002467) | 3.19906662 |
| 59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.18281701 |
| 60 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.17717476 |
| 61 | low-density lipoprotein particle clearance (GO:0034383) | 3.17362643 |
| 62 | positive regulation of interleukin-2 production (GO:0032743) | 3.16552190 |
| 63 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.15594268 |
| 64 | hypotonic response (GO:0006971) | 3.14967569 |
| 65 | positive regulation of acute inflammatory response (GO:0002675) | 3.13767599 |
| 66 | negative regulation of protein oligomerization (GO:0032460) | 3.13671365 |
| 67 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.12290351 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12122830 |
| 69 | cellular response to lipopolysaccharide (GO:0071222) | 3.07724197 |
| 70 | T cell selection (GO:0045058) | 3.07241865 |
| 71 | positive regulation of interleukin-4 production (GO:0032753) | 3.04925657 |
| 72 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.03934160 |
| 73 | positive T cell selection (GO:0043368) | 3.03393372 |
| 74 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.02179596 |
| 75 | T cell migration (GO:0072678) | 3.01888022 |
| 76 | membrane tubulation (GO:0097320) | 3.00599336 |
| 77 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.00421341 |
| 78 | cellular response to zinc ion (GO:0071294) | 3.00305530 |
| 79 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.99581313 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 2.98268875 |
| 81 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.96998563 |
| 82 | regulation of cholesterol storage (GO:0010885) | 2.93485893 |
| 83 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.93175619 |
| 84 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.93103857 |
| 85 | cellular response to molecule of bacterial origin (GO:0071219) | 2.91157880 |
| 86 | regulation of mononuclear cell migration (GO:0071675) | 2.89957330 |
| 87 | T cell costimulation (GO:0031295) | 2.89357888 |
| 88 | positive regulation of p38MAPK cascade (GO:1900745) | 2.89057639 |
| 89 | establishment of apical/basal cell polarity (GO:0035089) | 2.88280163 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.88094961 |
| 91 | growth hormone receptor signaling pathway (GO:0060396) | 2.87623517 |
| 92 | signal complex assembly (GO:0007172) | 2.85151584 |
| 93 | positive regulation of humoral immune response (GO:0002922) | 2.84881468 |
| 94 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.83741155 |
| 95 | response to protozoan (GO:0001562) | 2.82896931 |
| 96 | negative regulation of lipid storage (GO:0010888) | 2.82790917 |
| 97 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.82385595 |
| 98 | lymphocyte costimulation (GO:0031294) | 2.81826368 |
| 99 | face development (GO:0060324) | 2.81531397 |
| 100 | cellular response to nicotine (GO:0071316) | 2.81496945 |
| 101 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.81494320 |
| 102 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.80296700 |
| 103 | positive regulation of lipid storage (GO:0010884) | 2.76848245 |
| 104 | oxidative demethylation (GO:0070989) | 2.76227132 |
| 105 | glycosphingolipid catabolic process (GO:0046479) | 2.75056144 |
| 106 | regulation of interleukin-12 production (GO:0032655) | 2.74853060 |
| 107 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.74465321 |
| 108 | defense response to protozoan (GO:0042832) | 2.73511744 |
| 109 | mitotic G1/S transition checkpoint (GO:0044819) | 2.72818357 |
| 110 | negative regulation of viral genome replication (GO:0045071) | 2.71994427 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.71808101 |
| 112 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.71092523 |
| 113 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.70499660 |
| 114 | modulation by symbiont of host cellular process (GO:0044068) | 2.70378213 |
| 115 | regulation of RIG-I signaling pathway (GO:0039535) | 2.70155105 |
| 116 | regulation of T-helper cell differentiation (GO:0045622) | 2.69919988 |
| 117 | negative regulation of growth of symbiont in host (GO:0044130) | 2.69791315 |
| 118 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.69791315 |
| 119 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.69791315 |
| 120 | regulation of growth of symbiont in host (GO:0044126) | 2.69791315 |
| 121 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.69638053 |
| 122 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.69355598 |
| 123 | membrane raft organization (GO:0031579) | 2.68977025 |
| 124 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.68963266 |
| 125 | regulation of type 2 immune response (GO:0002828) | 2.68710848 |
| 126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.62880052 |
| 127 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62880052 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.62547118 |
| 129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61010909 |
| 130 | positive regulation of interleukin-6 production (GO:0032755) | 2.60882307 |
| 131 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.60565998 |
| 132 | myeloid dendritic cell differentiation (GO:0043011) | 2.59577857 |
| 133 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.58829407 |
| 134 | dendritic cell differentiation (GO:0097028) | 2.58334847 |
| 135 | cell adhesion mediated by integrin (GO:0033627) | 2.58210037 |
| 136 | positive regulation of protein oligomerization (GO:0032461) | 2.57759710 |
| 137 | decidualization (GO:0046697) | 2.57297710 |
| 138 | regulation of protein oligomerization (GO:0032459) | 2.57088028 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57050323 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56649322 |
| 141 | cellular response to ATP (GO:0071318) | 2.56596783 |
| 142 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.55051584 |
| 143 | negative regulation of viral release from host cell (GO:1902187) | 2.54955568 |
| 144 | regulation of interleukin-4 production (GO:0032673) | 2.54262178 |
| 145 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.54063870 |
| 146 | response to manganese ion (GO:0010042) | 2.53693016 |
| 147 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.53107313 |
| 148 | positive regulation by host of viral transcription (GO:0043923) | 2.52695554 |
| 149 | cellular response to biotic stimulus (GO:0071216) | 2.52136808 |
| 150 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.50950400 |
| 151 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.50804819 |
| 152 | positive regulation of interferon-beta production (GO:0032728) | 2.50231758 |
| 153 | acetyl-CoA metabolic process (GO:0006084) | 2.50195979 |
| 154 | negative regulation of Ras GTPase activity (GO:0034261) | 2.48374005 |
| 155 | labyrinthine layer development (GO:0060711) | 2.47240291 |
| 156 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.46344746 |
| 157 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.45745105 |
| 158 | regulation of T cell tolerance induction (GO:0002664) | 2.45058869 |
| 159 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44791057 |
| 160 | anatomical structure regression (GO:0060033) | 2.44187903 |
| 161 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.42145870 |
| 162 | positive regulation of astrocyte differentiation (GO:0048711) | 2.40679779 |
| 163 | G1 DNA damage checkpoint (GO:0044783) | 2.40481414 |
| 164 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.39913998 |
| 165 | leukocyte aggregation (GO:0070486) | 2.39906620 |
| 166 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39466210 |
| 167 | cellular response to growth hormone stimulus (GO:0071378) | 2.38683471 |
| 168 | oxygen transport (GO:0015671) | 2.38372479 |
| 169 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.37978710 |
| 170 | alkaloid metabolic process (GO:0009820) | 2.37056072 |
| 171 | response to laminar fluid shear stress (GO:0034616) | 2.36545180 |
| 172 | retinoic acid receptor signaling pathway (GO:0048384) | 2.36372596 |
| 173 | positive regulation of interleukin-17 production (GO:0032740) | 2.35811745 |
| 174 | sulfur amino acid catabolic process (GO:0000098) | 2.35152302 |
| 175 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.34006021 |
| 176 | establishment of monopolar cell polarity (GO:0061162) | 2.34006021 |
| 177 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.33610648 |
| 178 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.33441864 |
| 179 | positive regulation of type 2 immune response (GO:0002830) | 2.31472609 |
| 180 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.31068280 |
| 181 | negative regulation of interleukin-12 production (GO:0032695) | 2.30376886 |
| 182 | response to interleukin-15 (GO:0070672) | 2.29809663 |
| 183 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.29809626 |
| 184 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.29767343 |
| 185 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.29411208 |
| 186 | cellular response to virus (GO:0098586) | 2.28879278 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.39158356 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.29093947 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94881111 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.94319649 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90857332 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87510108 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.74139504 |
| 8 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.63803987 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.39447514 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.27505298 |
| 11 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26309909 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25062448 |
| 13 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.22046141 |
| 14 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.21555315 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.14486782 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.12794238 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09021756 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.06960787 |
| 19 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06372216 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05252381 |
| 21 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01978734 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01662287 |
| 23 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98646728 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.98454671 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.97987435 |
| 26 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.97538076 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.86737790 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86681029 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.84928643 |
| 30 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81686782 |
| 31 | * MAF_26560356_Chip-Seq_TH1_Human | 1.79518530 |
| 32 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.77189108 |
| 33 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.76937575 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.72269987 |
| 35 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.71280912 |
| 36 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.70717452 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.69535524 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68733517 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.67596258 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60656132 |
| 41 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.55244167 |
| 42 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.50938981 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50614136 |
| 44 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.49810200 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48461540 |
| 46 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47200722 |
| 47 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.46331794 |
| 48 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.45521988 |
| 49 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.45521988 |
| 50 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.45521988 |
| 51 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.44969824 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.44204223 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.41588524 |
| 54 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38211366 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36870681 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34627324 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34514716 |
| 58 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31792650 |
| 59 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30342645 |
| 60 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29137458 |
| 61 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27936372 |
| 62 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.25860235 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24012794 |
| 64 | * MAF_26560356_Chip-Seq_TH2_Human | 1.23217328 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23029300 |
| 66 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22903870 |
| 67 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.22627236 |
| 68 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.20789725 |
| 69 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.20396520 |
| 70 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19793568 |
| 71 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19489604 |
| 72 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18099841 |
| 73 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.17940918 |
| 74 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17491045 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17491045 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17220504 |
| 77 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16843496 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14781293 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14266510 |
| 80 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.13842032 |
| 81 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13662038 |
| 82 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13601349 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.13036201 |
| 84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12949466 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12911701 |
| 86 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11456531 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10565059 |
| 88 | MYB_26560356_Chip-Seq_TH2_Human | 1.08981592 |
| 89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08069902 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07208460 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06457567 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.06044626 |
| 93 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05832297 |
| 94 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05675864 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04956157 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04951365 |
| 97 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04684729 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02892194 |
| 99 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02557410 |
| 100 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02497327 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.02082177 |
| 102 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01948748 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01699083 |
| 104 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01663448 |
| 105 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01613822 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01047861 |
| 107 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01028941 |
| 108 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00584152 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.00553167 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99202875 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99181728 |
| 112 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99095728 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98921538 |
| 114 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98873064 |
| 115 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.98395339 |
| 116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96274316 |
| 117 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95859207 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95808699 |
| 119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95552353 |
| 120 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95552353 |
| 121 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95203701 |
| 122 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.94818422 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.94756631 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.94521480 |
| 125 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.94475581 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94242341 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.94084762 |
| 128 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93890797 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91556257 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.90924129 |
| 131 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89194065 |
| 132 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.88572750 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87301165 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.86001143 |
| 135 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84512381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.85696398 |
| 2 | MP0009278_abnormal_bone_marrow | 3.85608465 |
| 3 | MP0000685_abnormal_immune_system | 3.41082180 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.33266766 |
| 5 | MP0004510_myositis | 2.96533222 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.72696490 |
| 7 | MP0002332_abnormal_exercise_endurance | 2.69257921 |
| 8 | MP0005171_absent_coat_pigmentation | 2.67099895 |
| 9 | MP0003453_abnormal_keratinocyte_physiol | 2.65718093 |
| 10 | MP0003724_increased_susceptibility_to | 2.52905509 |
| 11 | MP0006082_CNS_inflammation | 2.19877785 |
| 12 | MP0008057_abnormal_DNA_replication | 2.11536785 |
| 13 | MP0008004_abnormal_stomach_pH | 2.04971453 |
| 14 | MP0002009_preneoplasia | 2.00608647 |
| 15 | MP0003075_altered_response_to | 1.99520203 |
| 16 | MP0004233_abnormal_muscle_weight | 1.97560677 |
| 17 | MP0002254_reproductive_system_inflammat | 1.90879582 |
| 18 | MP0009764_decreased_sensitivity_to | 1.86565872 |
| 19 | MP0003436_decreased_susceptibility_to | 1.83141310 |
| 20 | MP0003045_fibrosis | 1.78419461 |
| 21 | MP0002166_altered_tumor_susceptibility | 1.71819142 |
| 22 | MP0002933_joint_inflammation | 1.69989817 |
| 23 | MP0002405_respiratory_system_inflammati | 1.68331610 |
| 24 | MP0004947_skin_inflammation | 1.67345359 |
| 25 | MP0001533_abnormal_skeleton_physiology | 1.66247813 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.66221051 |
| 27 | MP0001348_abnormal_lacrimal_gland | 1.62701212 |
| 28 | MP0009840_abnormal_foam_cell | 1.62443197 |
| 29 | MP0005387_immune_system_phenotype | 1.61496135 |
| 30 | MP0001790_abnormal_immune_system | 1.61496135 |
| 31 | MP0002796_impaired_skin_barrier | 1.61069228 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.60527624 |
| 33 | MP0005257_abnormal_intraocular_pressure | 1.57851494 |
| 34 | MP0002419_abnormal_innate_immunity | 1.57688576 |
| 35 | MP0000920_abnormal_myelination | 1.57153991 |
| 36 | MP0005451_abnormal_body_composition | 1.54641089 |
| 37 | MP0003646_muscle_fatigue | 1.52309704 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.51255797 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.50643881 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.49718578 |
| 41 | MP0004381_abnormal_hair_follicle | 1.48223559 |
| 42 | MP0000343_altered_response_to | 1.47411625 |
| 43 | MP0005671_abnormal_response_to | 1.46755700 |
| 44 | MP0001800_abnormal_humoral_immune | 1.42909699 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.42413075 |
| 46 | MP0010630_abnormal_cardiac_muscle | 1.42129872 |
| 47 | MP0005330_cardiomyopathy | 1.41825443 |
| 48 | MP0004134_abnormal_chest_morphology | 1.41545872 |
| 49 | MP0008775_abnormal_heart_ventricle | 1.39632760 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.38428066 |
| 51 | MP0002006_tumorigenesis | 1.38237763 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.38109420 |
| 53 | MP0003091_abnormal_cell_migration | 1.37639553 |
| 54 | MP0000751_myopathy | 1.37150834 |
| 55 | MP0000579_abnormal_nail_morphology | 1.37065854 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.35587289 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.34875153 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.34572523 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.34500682 |
| 60 | MP0003191_abnormal_cellular_cholesterol | 1.33920499 |
| 61 | MP0003195_calcinosis | 1.32916414 |
| 62 | MP0005365_abnormal_bile_salt | 1.32414738 |
| 63 | MP0008469_abnormal_protein_level | 1.32310347 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.31025890 |
| 65 | MP0002269_muscular_atrophy | 1.29835342 |
| 66 | MP0002282_abnormal_trachea_morphology | 1.28547809 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.28058892 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.27820028 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.27820028 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.25268527 |
| 71 | MP0003828_pulmonary_edema | 1.24712477 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.22738094 |
| 73 | MP0000858_altered_metastatic_potential | 1.21966100 |
| 74 | MP0010030_abnormal_orbit_morphology | 1.21832373 |
| 75 | MP0001873_stomach_inflammation | 1.19479338 |
| 76 | MP0001835_abnormal_antigen_presentation | 1.19137126 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.16534807 |
| 78 | MP0002723_abnormal_immune_serum | 1.16490836 |
| 79 | MP0001853_heart_inflammation | 1.15883493 |
| 80 | MP0001340_abnormal_eyelid_morphology | 1.15519549 |
| 81 | MP0005166_decreased_susceptibility_to | 1.15428576 |
| 82 | MP0003690_abnormal_glial_cell | 1.12614543 |
| 83 | MP0008995_early_reproductive_senescence | 1.12312693 |
| 84 | MP0004858_abnormal_nervous_system | 1.11853210 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.11604159 |
| 86 | MP0003329_amyloid_beta_deposits | 1.10679512 |
| 87 | MP0003303_peritoneal_inflammation | 1.09437296 |
| 88 | MP0005025_abnormal_response_to | 1.08346204 |
| 89 | MP0005023_abnormal_wound_healing | 1.08108338 |
| 90 | MP0005083_abnormal_biliary_tract | 1.06315043 |
| 91 | MP0003137_abnormal_impulse_conducting | 1.04940162 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 1.04636777 |
| 93 | MP0009785_altered_susceptibility_to | 1.03068349 |
| 94 | MP0004130_abnormal_muscle_cell | 1.01024218 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 1.00642204 |
| 96 | MP0002452_abnormal_antigen_presenting | 0.99599709 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.98245120 |
| 98 | MP0003879_abnormal_hair_cell | 0.97923934 |
| 99 | MP0000733_abnormal_muscle_development | 0.96946214 |
| 100 | MP0002398_abnormal_bone_marrow | 0.95657536 |
| 101 | MP0002420_abnormal_adaptive_immunity | 0.94846878 |
| 102 | MP0005360_urolithiasis | 0.93810802 |
| 103 | MP0000750_abnormal_muscle_regeneration | 0.93759815 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.93685151 |
| 105 | MP0001819_abnormal_immune_cell | 0.93250827 |
| 106 | MP0005165_increased_susceptibility_to | 0.92742972 |
| 107 | MP0002060_abnormal_skin_morphology | 0.92185369 |
| 108 | MP0002106_abnormal_muscle_physiology | 0.91131552 |
| 109 | MP0006054_spinal_hemorrhage | 0.90874325 |
| 110 | MP0005310_abnormal_salivary_gland | 0.90754573 |
| 111 | MP0000609_abnormal_liver_physiology | 0.90641667 |
| 112 | MP0005501_abnormal_skin_physiology | 0.90567970 |
| 113 | MP0001849_ear_inflammation | 0.89016028 |
| 114 | MP0000716_abnormal_immune_system | 0.88244710 |
| 115 | MP0003950_abnormal_plasma_membrane | 0.87150303 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.86337787 |
| 117 | MP0008260_abnormal_autophagy | 0.85147125 |
| 118 | MP0003806_abnormal_nucleotide_metabolis | 0.84704589 |
| 119 | MP0000371_diluted_coat_color | 0.84479256 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.84346997 |
| 121 | MP0008874_decreased_physiological_sensi | 0.82448127 |
| 122 | MP0003634_abnormal_glial_cell | 0.79862044 |
| 123 | MP0003866_abnormal_defecation | 0.79798156 |
| 124 | MP0004036_abnormal_muscle_relaxation | 0.78910806 |
| 125 | MP0005390_skeleton_phenotype | 0.78859811 |
| 126 | MP0005647_abnormal_sex_gland | 0.78593968 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.78115311 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.77992213 |
| 129 | MP0005164_abnormal_response_to | 0.77919254 |
| 130 | MP0005248_abnormal_Harderian_gland | 0.76148405 |
| 131 | MP0002971_abnormal_brown_adipose | 0.76032306 |
| 132 | MP0002722_abnormal_immune_system | 0.75363455 |
| 133 | MP0000604_amyloidosis | 0.74608399 |
| 134 | MP0010307_abnormal_tumor_latency | 0.74246410 |
| 135 | MP0003448_altered_tumor_morphology | 0.74016236 |
| 136 | MP0002138_abnormal_hepatobiliary_system | 0.72690594 |
| 137 | MP0000470_abnormal_stomach_morphology | 0.72374525 |
| 138 | MP0005266_abnormal_metabolism | 0.72266351 |
| 139 | MP0000762_abnormal_tongue_morphology | 0.71928837 |
| 140 | MP0009763_increased_sensitivity_to | 0.71541651 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70694602 |
| 142 | MP0003656_abnormal_erythrocyte_physiolo | 0.70221343 |
| 143 | MP0000747_muscle_weakness | 0.70180113 |
| 144 | MP0009115_abnormal_fat_cell | 0.69656257 |
| 145 | MP0001346_abnormal_lacrimal_gland | 0.68456368 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.66697771 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.64664246 |
| 148 | MP0001542_abnormal_bone_strength | 0.64137175 |
| 149 | MP0009765_abnormal_xenobiotic_induced | 0.63483463 |
| 150 | MP0005319_abnormal_enzyme/_coenzyme | 0.62675048 |
| 151 | MP0004808_abnormal_hematopoietic_stem | 0.62451131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 5.37166095 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.37166095 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.37166095 |
| 4 | Increased IgM level (HP:0003496) | 4.72177599 |
| 5 | Nuclear cataract (HP:0100018) | 4.34788515 |
| 6 | Pustule (HP:0200039) | 4.30404506 |
| 7 | Loss of speech (HP:0002371) | 4.26752369 |
| 8 | Orchitis (HP:0100796) | 4.19033323 |
| 9 | Optic neuritis (HP:0100653) | 4.11548743 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.11548743 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.08716877 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.72006838 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.64751217 |
| 14 | Premature skin wrinkling (HP:0100678) | 3.56063355 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.52757533 |
| 16 | Alopecia of scalp (HP:0002293) | 3.50244006 |
| 17 | Ulnar bowing (HP:0003031) | 3.32726501 |
| 18 | Thin bony cortex (HP:0002753) | 3.27395025 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.22666347 |
| 20 | T lymphocytopenia (HP:0005403) | 3.21837779 |
| 21 | Turricephaly (HP:0000262) | 3.21623679 |
| 22 | Apathy (HP:0000741) | 3.19871665 |
| 23 | Abnormality of T cell number (HP:0011839) | 3.15614417 |
| 24 | Myositis (HP:0100614) | 3.10299366 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.07242529 |
| 26 | Disinhibition (HP:0000734) | 3.05732026 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.05208952 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.05208952 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.05208952 |
| 30 | Myocardial infarction (HP:0001658) | 3.03822849 |
| 31 | Mucopolysacchariduria (HP:0008155) | 3.00058908 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00058908 |
| 33 | Annular pancreas (HP:0001734) | 2.99039894 |
| 34 | Exercise-induced myalgia (HP:0003738) | 2.96760513 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.96291624 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.93048976 |
| 37 | Male infertility (HP:0003251) | 2.91291889 |
| 38 | Hypoplastic ischia (HP:0003175) | 2.91264782 |
| 39 | Diminished motivation (HP:0000745) | 2.90703805 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.89847232 |
| 41 | Axonal loss (HP:0003447) | 2.88137761 |
| 42 | Abnormal hemoglobin (HP:0011902) | 2.86851356 |
| 43 | Coronal craniosynostosis (HP:0004440) | 2.86017356 |
| 44 | Rib fusion (HP:0000902) | 2.81990494 |
| 45 | Diaphragmatic weakness (HP:0009113) | 2.79806464 |
| 46 | Concave nail (HP:0001598) | 2.77302431 |
| 47 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.68935557 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.66541827 |
| 49 | Glomerulonephritis (HP:0000099) | 2.66448465 |
| 50 | Stomatitis (HP:0010280) | 2.66255752 |
| 51 | Abnormality of the ischium (HP:0003174) | 2.65348074 |
| 52 | Mutism (HP:0002300) | 2.63792642 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.59513997 |
| 54 | Hyperparathyroidism (HP:0000843) | 2.58752126 |
| 55 | Complement deficiency (HP:0004431) | 2.51234373 |
| 56 | Poikiloderma (HP:0001029) | 2.49758623 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.49450882 |
| 58 | Abnormality of the aortic arch (HP:0012303) | 2.48295665 |
| 59 | Neuronal loss in central nervous system (HP:0002529) | 2.46681845 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 2.45385588 |
| 61 | Recurrent fungal infections (HP:0002841) | 2.44305712 |
| 62 | Increased serum ferritin (HP:0003281) | 2.43814187 |
| 63 | Muscle fiber splitting (HP:0003555) | 2.41586371 |
| 64 | Cerebral aneurysm (HP:0004944) | 2.39486327 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39270702 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.39247637 |
| 67 | Intestinal fistula (HP:0100819) | 2.37888222 |
| 68 | Hypochromic microcytic anemia (HP:0004840) | 2.37410609 |
| 69 | Vertebral hypoplasia (HP:0008417) | 2.34330316 |
| 70 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.34330316 |
| 71 | Abnormality of male internal genitalia (HP:0000022) | 2.30577434 |
| 72 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.30012213 |
| 73 | Deep venous thrombosis (HP:0002625) | 2.29605608 |
| 74 | Facial hemangioma (HP:0000329) | 2.28717091 |
| 75 | Metaphyseal irregularity (HP:0003025) | 2.28119425 |
| 76 | Sudden death (HP:0001699) | 2.25617012 |
| 77 | Alacrima (HP:0000522) | 2.22944644 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.22881366 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.22084830 |
| 80 | Rectal fistula (HP:0100590) | 2.21867671 |
| 81 | Rectovaginal fistula (HP:0000143) | 2.21867671 |
| 82 | Large for gestational age (HP:0001520) | 2.21435233 |
| 83 | Metaphyseal cupping (HP:0003021) | 2.21169048 |
| 84 | Gangrene (HP:0100758) | 2.20818731 |
| 85 | Malnutrition (HP:0004395) | 2.20794555 |
| 86 | Achilles tendon contracture (HP:0001771) | 2.20340853 |
| 87 | Peripheral hypomyelination (HP:0007182) | 2.18743525 |
| 88 | Polycythemia (HP:0001901) | 2.18742835 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.18670382 |
| 90 | Albinism (HP:0001022) | 2.17527078 |
| 91 | Congenital hip dislocation (HP:0001374) | 2.16726473 |
| 92 | Ventricular tachycardia (HP:0004756) | 2.16377832 |
| 93 | Abnormality of complement system (HP:0005339) | 2.16006936 |
| 94 | Bone pain (HP:0002653) | 2.15590520 |
| 95 | Hamartoma (HP:0010566) | 2.14751466 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14404777 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.13564726 |
| 98 | Muscle fibrillation (HP:0010546) | 2.11993023 |
| 99 | Abnormality of the Achilles tendon (HP:0005109) | 2.10658850 |
| 100 | Vertebral compression fractures (HP:0002953) | 2.08414682 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.07975187 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07132177 |
| 103 | Depressed nasal tip (HP:0000437) | 2.06850545 |
| 104 | Amyloidosis (HP:0011034) | 2.06644920 |
| 105 | Hypotrichosis (HP:0001006) | 2.05793179 |
| 106 | IgA deficiency (HP:0002720) | 2.04389740 |
| 107 | Anteriorly placed anus (HP:0001545) | 2.03865583 |
| 108 | Clumsiness (HP:0002312) | 1.99745229 |
| 109 | Eczematoid dermatitis (HP:0000976) | 1.95447776 |
| 110 | Peripheral demyelination (HP:0011096) | 1.94501839 |
| 111 | Increased IgE level (HP:0003212) | 1.94477686 |
| 112 | Increased CSF protein (HP:0002922) | 1.94057499 |
| 113 | Popliteal pterygium (HP:0009756) | 1.93790736 |
| 114 | Vaginal fistula (HP:0004320) | 1.92905060 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 1.91249652 |
| 116 | Ulnar claw (HP:0001178) | 1.90651254 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.89858128 |
| 118 | Flat acetabular roof (HP:0003180) | 1.89847479 |
| 119 | Aplasia of the musculature (HP:0100854) | 1.87891064 |
| 120 | Broad alveolar ridges (HP:0000187) | 1.87521154 |
| 121 | Arterial thrombosis (HP:0004420) | 1.87233620 |
| 122 | Bulbar palsy (HP:0001283) | 1.86738695 |
| 123 | Right ventricular cardiomyopathy (HP:0011663) | 1.86563920 |
| 124 | Progressive neurologic deterioration (HP:0002344) | 1.86492746 |
| 125 | Onion bulb formation (HP:0003383) | 1.86090635 |
| 126 | Tongue fasciculations (HP:0001308) | 1.85773779 |
| 127 | Nausea (HP:0002018) | 1.82638420 |
| 128 | Abnormality of T cells (HP:0002843) | 1.82186898 |
| 129 | Xanthomatosis (HP:0000991) | 1.81619242 |
| 130 | Abnormality of the nasal septum (HP:0000419) | 1.80877425 |
| 131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80018021 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.79246496 |
| 133 | Elevated alkaline phosphatase (HP:0003155) | 1.78858345 |
| 134 | Intrahepatic cholestasis (HP:0001406) | 1.78836851 |
| 135 | Exercise-induced muscle cramps (HP:0003710) | 1.78682162 |
| 136 | Hypercortisolism (HP:0001578) | 1.77896939 |
| 137 | Palmoplantar hyperkeratosis (HP:0000972) | 1.77832363 |
| 138 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.76247291 |
| 139 | Difficulty running (HP:0009046) | 1.76018559 |
| 140 | Pathologic fracture (HP:0002756) | 1.75454198 |
| 141 | Thoracolumbar scoliosis (HP:0002944) | 1.75286586 |
| 142 | Bowed forearm bones (HP:0003956) | 1.75162308 |
| 143 | Bowing of the arm (HP:0006488) | 1.75162308 |
| 144 | Fused cervical vertebrae (HP:0002949) | 1.74760373 |
| 145 | Supranuclear gaze palsy (HP:0000605) | 1.74665840 |
| 146 | Acne (HP:0001061) | 1.74547488 |
| 147 | Joint stiffness (HP:0001387) | 1.74523769 |
| 148 | Upper limb amyotrophy (HP:0009129) | 1.73664516 |
| 149 | Distal upper limb amyotrophy (HP:0007149) | 1.73664516 |
| 150 | Protuberant abdomen (HP:0001538) | 1.73230361 |
| 151 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.72432832 |
| 152 | IgG deficiency (HP:0004315) | 1.71805327 |
| 153 | Hypobetalipoproteinemia (HP:0003563) | 1.70964071 |
| 154 | Aseptic necrosis (HP:0010885) | 1.70303583 |
| 155 | Increased connective tissue (HP:0009025) | 1.70282038 |
| 156 | Gastrointestinal infarctions (HP:0005244) | 1.69264494 |
| 157 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.69163617 |
| 158 | Split hand (HP:0001171) | 1.68508495 |
| 159 | Dementia (HP:0000726) | 1.68390861 |
| 160 | Peritonitis (HP:0002586) | 1.67844190 |
| 161 | Epiphyseal dysplasia (HP:0002656) | 1.67001712 |
| 162 | Pulmonary infiltrates (HP:0002113) | 1.66912553 |
| 163 | Abnormality of the thoracic spine (HP:0100711) | 1.66335769 |
| 164 | Abnormality of the endocardium (HP:0004306) | 1.65770826 |
| 165 | Lower limb hyperreflexia (HP:0002395) | 1.65759413 |
| 166 | Vertebral fusion (HP:0002948) | 1.65568570 |
| 167 | Bundle branch block (HP:0011710) | 1.65521532 |
| 168 | Parakeratosis (HP:0001036) | 1.65217474 |
| 169 | Zonular cataract (HP:0010920) | 1.65131837 |
| 170 | Colitis (HP:0002583) | 1.64752300 |
| 171 | Cervical subluxation (HP:0003308) | 1.64719460 |
| 172 | Severe combined immunodeficiency (HP:0004430) | 1.64475224 |
| 173 | Rickets (HP:0002748) | 1.64197897 |
| 174 | Broad face (HP:0000283) | 1.63515364 |
| 175 | Thoracic kyphosis (HP:0002942) | 1.63133336 |
| 176 | Esophageal varix (HP:0002040) | 1.62938993 |
| 177 | Purpura (HP:0000979) | 1.62927555 |
| 178 | Delayed epiphyseal ossification (HP:0002663) | 1.62393223 |
| 179 | Hyperacusis (HP:0010780) | 1.61815986 |
| 180 | Joint swelling (HP:0001386) | 1.61068897 |
| 181 | Hypoalphalipoproteinemia (HP:0003233) | 1.61051562 |
| 182 | Decreased lacrimation (HP:0000633) | 1.60867563 |
| 183 | Hypochromic anemia (HP:0001931) | 1.60782771 |
| 184 | Polyneuropathy (HP:0001271) | 1.60642495 |
| 185 | Inflammation of the large intestine (HP:0002037) | 1.60525014 |
| 186 | J-shaped sella turcica (HP:0002680) | 1.60296567 |
| 187 | Increased mean platelet volume (HP:0011877) | 1.59906064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.60504816 |
| 2 | ICK | 4.75655161 |
| 3 | TYRO3 | 3.58131707 |
| 4 | DDR2 | 3.24892058 |
| 5 | TAOK2 | 3.20191673 |
| 6 | EPHB1 | 3.12893960 |
| 7 | NME2 | 2.85789032 |
| 8 | CSK | 2.45910790 |
| 9 | MAP3K11 | 2.38369753 |
| 10 | FGFR4 | 2.35006208 |
| 11 | MOS | 2.32509347 |
| 12 | MAPK15 | 2.27486422 |
| 13 | GRK7 | 2.26677030 |
| 14 | BMX | 2.18484109 |
| 15 | FGR | 2.11098744 |
| 16 | MAP4K1 | 2.08219676 |
| 17 | MAP3K6 | 2.06206367 |
| 18 | TRIB3 | 2.00841841 |
| 19 | EPHA3 | 1.79733707 |
| 20 | TRPM7 | 1.76176419 |
| 21 | PIM2 | 1.64534828 |
| 22 | PDGFRA | 1.57205422 |
| 23 | MAP3K14 | 1.54447144 |
| 24 | EPHA2 | 1.51061768 |
| 25 | JAK3 | 1.46245196 |
| 26 | PINK1 | 1.42026388 |
| 27 | TXK | 1.41917637 |
| 28 | DYRK1B | 1.40476165 |
| 29 | PRKD2 | 1.38016992 |
| 30 | SIK1 | 1.35427906 |
| 31 | TTN | 1.35035778 |
| 32 | TBK1 | 1.33617623 |
| 33 | IRAK4 | 1.32569283 |
| 34 | MAP3K10 | 1.30417919 |
| 35 | ARAF | 1.28532461 |
| 36 | MAP3K13 | 1.25756236 |
| 37 | UHMK1 | 1.25752937 |
| 38 | ITK | 1.25289722 |
| 39 | TYK2 | 1.25283258 |
| 40 | PDGFRB | 1.22954453 |
| 41 | PHKG2 | 1.22010937 |
| 42 | PHKG1 | 1.22010937 |
| 43 | MAP3K9 | 1.18686319 |
| 44 | MAP2K3 | 1.18480181 |
| 45 | IKBKB | 1.16836622 |
| 46 | MATK | 1.15003910 |
| 47 | PIM1 | 1.14743877 |
| 48 | IRAK2 | 1.10653873 |
| 49 | DMPK | 1.08845290 |
| 50 | IKBKE | 1.08412229 |
| 51 | CHUK | 1.05825560 |
| 52 | STK39 | 1.04854657 |
| 53 | GSK3A | 1.04279747 |
| 54 | MAP3K1 | 1.02941829 |
| 55 | MAP3K5 | 1.00171256 |
| 56 | CDK12 | 0.98416243 |
| 57 | SMG1 | 0.98292864 |
| 58 | PKN2 | 0.95783068 |
| 59 | FGFR3 | 0.94877861 |
| 60 | JAK1 | 0.93762186 |
| 61 | NLK | 0.92061603 |
| 62 | STK10 | 0.90901582 |
| 63 | MST1R | 0.87420522 |
| 64 | ZAP70 | 0.87220921 |
| 65 | CDC42BPA | 0.86253686 |
| 66 | LCK | 0.85093472 |
| 67 | TGFBR2 | 0.85052649 |
| 68 | CLK1 | 0.81692662 |
| 69 | YES1 | 0.81492470 |
| 70 | MST4 | 0.81216195 |
| 71 | MAPK11 | 0.78495071 |
| 72 | PTK6 | 0.76252963 |
| 73 | PAK4 | 0.75315722 |
| 74 | ABL2 | 0.74095722 |
| 75 | JAK2 | 0.73560698 |
| 76 | CDK6 | 0.73111040 |
| 77 | TESK1 | 0.72285879 |
| 78 | PKN1 | 0.72069963 |
| 79 | RIPK1 | 0.71749639 |
| 80 | MAP3K3 | 0.69038945 |
| 81 | HIPK2 | 0.67816527 |
| 82 | TESK2 | 0.67721814 |
| 83 | PRPF4B | 0.66815256 |
| 84 | MARK3 | 0.66762143 |
| 85 | MTOR | 0.66093621 |
| 86 | RPS6KA6 | 0.65220383 |
| 87 | RPS6KL1 | 0.65196713 |
| 88 | RPS6KC1 | 0.65196713 |
| 89 | BLK | 0.63625321 |
| 90 | MAP3K7 | 0.62980311 |
| 91 | BMPR2 | 0.61953725 |
| 92 | PTK2 | 0.61723931 |
| 93 | EGFR | 0.60368472 |
| 94 | INSR | 0.59399952 |
| 95 | HCK | 0.58933350 |
| 96 | EPHB2 | 0.58753177 |
| 97 | IRAK1 | 0.58301439 |
| 98 | RPS6KA1 | 0.57878636 |
| 99 | PRKD1 | 0.57015302 |
| 100 | MET | 0.56787803 |
| 101 | FGFR1 | 0.54297988 |
| 102 | DYRK3 | 0.54006739 |
| 103 | RPS6KA2 | 0.52451129 |
| 104 | LMTK2 | 0.51981826 |
| 105 | ROCK2 | 0.50551259 |
| 106 | PRKCH | 0.49974005 |
| 107 | EEF2K | 0.47410420 |
| 108 | CDK9 | 0.46834786 |
| 109 | PRKAA1 | 0.46750336 |
| 110 | CAMK1D | 0.46396675 |
| 111 | SIK3 | 0.46330940 |
| 112 | PRKCQ | 0.46259440 |
| 113 | NEK9 | 0.46254610 |
| 114 | MELK | 0.46241409 |
| 115 | SIK2 | 0.45515966 |
| 116 | RET | 0.45262247 |
| 117 | MAPK4 | 0.45240588 |
| 118 | OBSCN | 0.44476307 |
| 119 | KSR2 | 0.44130743 |
| 120 | LATS2 | 0.43678027 |
| 121 | WNK4 | 0.42554336 |
| 122 | PRKAA2 | 0.42400046 |
| 123 | LRRK2 | 0.41838039 |
| 124 | BRAF | 0.41697968 |
| 125 | PAK3 | 0.40363318 |
| 126 | MARK2 | 0.39844967 |
| 127 | PDPK1 | 0.38902889 |
| 128 | WNK1 | 0.38645803 |
| 129 | LIMK1 | 0.38318150 |
| 130 | TAOK1 | 0.38034757 |
| 131 | FGFR2 | 0.36486012 |
| 132 | MAP3K8 | 0.35746388 |
| 133 | ERN1 | 0.35705429 |
| 134 | PAK6 | 0.33034343 |
| 135 | STK24 | 0.32114125 |
| 136 | MAPK1 | 0.31961900 |
| 137 | MAPKAPK2 | 0.31332860 |
| 138 | LATS1 | 0.31236087 |
| 139 | PRKD3 | 0.31013338 |
| 140 | RIPK4 | 0.28067792 |
| 141 | MUSK | 0.27951091 |
| 142 | DAPK3 | 0.27131141 |
| 143 | CDK15 | 0.26616868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.85330137 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98889742 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.67536879 |
| 4 | Viral myocarditis_Homo sapiens_hsa05416 | 2.62425853 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53542043 |
| 6 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.27613589 |
| 7 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.18549601 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.13021150 |
| 9 | Prion diseases_Homo sapiens_hsa05020 | 2.02105970 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.98455678 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.93331751 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93010841 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 1.92060177 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87837781 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.80489856 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74313350 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.73784270 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.70548880 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68504637 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66925732 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66002488 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.65515231 |
| 23 | Adherens junction_Homo sapiens_hsa04520 | 1.62509366 |
| 24 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59921163 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59911685 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55138041 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.54342565 |
| 28 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.54327084 |
| 29 | Bladder cancer_Homo sapiens_hsa05219 | 1.53562969 |
| 30 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.51751346 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49545990 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.38630655 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36663968 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.35880632 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.32713502 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29702740 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.23925300 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22215438 |
| 39 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.21237076 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.18703036 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14721882 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08407678 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07123002 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06518537 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.05192487 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04689049 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02720256 |
| 48 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.02080890 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01724648 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99899432 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.97603023 |
| 52 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96867579 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96335435 |
| 54 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.95941356 |
| 55 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.95606652 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95034160 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92924113 |
| 58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.89746411 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88262407 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86334393 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86127915 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.86075509 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83698566 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83493411 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.83252306 |
| 66 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83205987 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83021738 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.82657591 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82270825 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81191609 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81086811 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80754300 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78481353 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77410447 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77100446 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75684835 |
| 77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74777780 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.74547845 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74506346 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.74187219 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.74108449 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74097432 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73420468 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73169549 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.71649472 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.71491100 |
| 87 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70970040 |
| 88 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70860389 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69257498 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68817558 |
| 91 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68537236 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67307706 |
| 93 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66145791 |
| 94 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66036288 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.65642225 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.65568292 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64567037 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64293060 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64035631 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62326093 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.61697993 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.60904986 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60226920 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59884009 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59677793 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.59481841 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59476632 |
| 108 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58645074 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58482581 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57775671 |
| 111 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57536265 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57097474 |
| 113 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57065427 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56585497 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55054210 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54725877 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.54433179 |
| 118 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53951440 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53692032 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53598901 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53215130 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52077864 |
| 123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51920550 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.50715824 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49791812 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49155236 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.47391607 |
| 128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47179124 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.46185760 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42195248 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39226586 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37411258 |
| 133 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37269552 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36985828 |
| 135 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36355850 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35837796 |
| 137 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33604852 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.31990986 |

